Formodual

Leaflet accompanying the packaging: information for the user

Formodual, (200 micrograms + 6 micrograms)/inhalation dose, inhalation aerosol, solution

Solution
Beclometasone dipropionate + Formoterol fumarate dihydrate
Medicine intended for use in adults.

You should carefully read the contents of the leaflet before using the medicine, as it contains important information for the patient.

• You should keep this leaflet, so that you can read it again if you need to.
• In case of any doubts, you should consult a doctor, pharmacist, or nurse.
• This medicine has been prescribed specifically for you. Do not pass it on to others. The medicine may harm another person, even if their symptoms are the same.
• If the patient experiences any side effects, including any side effects not listed in this leaflet, they should tell their doctor, pharmacist, or nurse. See section 4.

Table of contents of the leaflet

• 1. What is Formodual and what is it used for
• 2. Important information before using Formodual
• 3. How to use Formodual
• 4. Possible side effects
• 5. How to store Formodual
• 6. Contents of the packaging and other information

1. What is Formodual and what is it used for

Formodual is a solution in an inhalation aerosol, containing two active substances, which are delivered directly to the lungs when you inhale through the mouthpiece of the inhaler.
The medicine contains two active substances:
Beclometasone dipropionate, belonging to a group of medicines called corticosteroids, which have an anti-inflammatory effect by reducing swelling and irritation of the lungs.
Formoterol fumarate dihydrate, belonging to a group of long-acting bronchodilators, which relax the muscles in the airways and make breathing easier.
Together, these two active substances make breathing easier. They also help prevent asthma symptoms, such as shortness of breath, wheezing, and coughing.

Formodual is intended for the treatment of asthma in adults.

Formodual is used in patients whose:

• asthma symptoms are not adequately controlled with inhaled corticosteroids and a short-acting bronchodilator used as needed, or
• asthma symptoms are adequately controlled with both inhaled corticosteroids and long-acting bronchodilators.

1/10

2. Important information before using Formodual

When not to use Formodual:

Warnings and precautions

Before starting treatment with Formodual, you should discuss it with your doctor, pharmacist, or nurse:

Before using Formodual, you should always inform your doctor if any of the above warnings apply to you.

Before using this medicine, you should consult a doctor, pharmacist, or nurse if you have any current or past health problems or allergies, or if you have any doubts about whether Formodual can be used.

The doctor may occasionally order a blood test to check potassium levels, especially

in patients with severe asthma.Like other bronchodilators, Formodual may cause a sudden decrease in potassium levels in the blood (hypokalemia). This is related to oxygen deficiency in the blood caused by taking other medicines at the same time as Formodual, which may exacerbate the decrease in potassium levels in the blood.
2/10
If the patient is taking large doses of inhaled corticosteroids for a long time, they may be more likely to require corticosteroid administration during periods of stress. Stressful situations may include hospitalization after an accident, serious injury, or waiting for surgery. In such situations, the doctor will decide on the possible increase in corticosteroid dose or may prescribe other steroids in the form of tablets or injections.
If hospitalization is necessary, the patient should remember to bring all their medicines and inhalers, including Formodual, as well as over-the-counter medicines, if possible, in their original packaging.

If the patient experiences blurred vision or other vision disturbances, they should contact their doctor.

Children and adolescents

Formodual should not be used in children and adolescents under the age of 18.

Formodual and other medicines

You should tell your doctor, pharmacist, or nurse about all the medicines you are currently taking or have recently taken, including those available without a prescription.
This is necessary because Formodual may affect the action of some other medicines.
Similarly, some medicines may affect the action of Formodual.
In particular, you should tell your doctor, pharmacist, or nurse if you are taking any of the following medicines:

• some medicines may enhance the effect of Formodual, and the doctor may want to closely monitor the condition of the patient taking such medicines (including some HIV medicines: ritonavir, cobicistat);
• beta-blockers. Beta-blockers are medicines used to treat many diseases, including heart disease, high blood pressure, and glaucoma (increased pressure in the eye). If the administration of beta-blockers is necessary (including eye drops), the effect of formoterol may be reduced or formoterol may not work at all;
• medicines that stimulate beta-adrenergic receptors (medicines that work in the same way as formoterol) - may enhance the effect of formoterol;
• medicines used to treat irregular heartbeat (quinidine, disopyramide, procainamide);
• medicines used to treat allergies (antihistamines);
• medicines used to treat symptoms of depression or mental disorders, such as monoamine oxidase inhibitors (e.g., phenelzine and isocarboxazid), tricyclic antidepressants (e.g., amitriptyline and imipramine), phenothiazines;
• medicines used to treat Parkinson's disease (L-dopa);
• medicines used to treat hypothyroidism (L-thyroxine);
• medicines containing oxytocin (which cause uterine contractions);
• medicines used to treat mental disorders, such as monoamine oxidase inhibitors (MAOIs) or medicines with similar properties, such as furazolidone and procarbazine;
• medicines used to treat heart disease (digoxin);
• other medicines used to treat asthma (theophylline, aminophylline, or steroids);
• diuretics.

You should also inform your doctor if you are scheduled to undergo general anesthesia for surgery or a dental procedure.

Pregnancy, breastfeeding, and fertility

There are no clinical data on the use of Formodual during pregnancy.
Formodual should not be used if the patient is pregnant, thinks they may be pregnant, or plans to have a child, or if the patient is breastfeeding, unless the doctor decides otherwise.
3/10

Driving and using machines

It is unlikely that Formodual will affect the ability to drive and use machines.

Formodual contains alcohol

Formodual contains 9 mg of alcohol (ethanol) per inhalation, which is equivalent to 0.25 mg/kg body weight per dose, when two inhalations are used. The amount of alcohol in two inhalations of this medicine is equivalent to less than 1 ml of beer or wine. The small amount of alcohol in this medicine is unlikely to have noticeable effects.

3. How to use Formodual

This medicine should always be used in accordance with the recommendations of a doctor or pharmacist. In case of doubts, you should consult a doctor or pharmacist.
The doctor will regularly check if the patient is taking the optimal dose of Formodual. The doctor will determine the smallest dose that provides the best control of asthma symptoms.

Dosage: Adults and the elderly

The recommended dose of the medicine is two inhalations twice a day.
The maximum daily dose is 4 inhalations.

Remember: You should always have a fast-acting inhaled reliever medicine with you to treat asthma symptoms or a sudden asthma attack.

Special patient groups:

There is no need to adjust the dosage in elderly patients. There is no information on the use of Formodual in patients with liver or kidney function disorders.

Use in children and adolescents under 18 years of age:

This medicine should NOT be used in children and adolescents under 18 years of age.

The dose of beclometasone dipropionate in Formodual, which is effective in treating asthma, may be lower than the dose contained in other inhaled medicines containing beclometasone dipropionate. If the patient has previously used another inhaled medicine

containing beclometasone dipropionate, the doctor will recommend the appropriate dose of Formodual.

Do not increase the dose.

If you feel that the effect of the medicine is insufficient, you should always consult a doctor before increasing the dose of the medicine.

In case of worsening asthma symptoms:

In case of worsening of the disease or difficulties in controlling it (e.g., when the patient needs to use another inhaled reliever medicine more frequently) or when the inhaled reliever medicine does not relieve symptoms, you should immediately inform your doctor. This may indicate worsening of asthma, and the doctor may decide to change the dosage of Formodual or use other treatment.

Method of administration:

Formodual is intended for inhalation use.

This medicine is in a pressurized container, in a plastic casing with a mouthpiece. At the back of the inhaler, there is a dose counter that shows how many doses of the medicine are left. After each press of the inhaler, a dose of the medicine is released, and the counter will show one dose less. Be careful not to drop the inhaler, as this may cause the counter to decrement.

Inhaler test:

Before using the inhaler for the first time, or if the inhaler has not been used for 14 days or more, you should perform an inhaler test to ensure it is working properly.

• Remove the protective cap from the mouthpiece.
• Hold the canister in an upright position with the mouthpiece pointing downwards.
• Point the mouthpiece away from you and firmly press the top of the canister to release one inhalation.
• Check the dose counter. If the inhaler is being tested for the first time, the dose counter should show 120.

How to use the inhaler:

If possible, you should stand or sit upright while inhaling.
Before inhaling, check the dose counter: any value between "1" and "120" indicates that there are still doses of the medicine left in the canister. If the dose counter shows "0", it means that there are no more doses of the medicine left, and you should discard the old inhaler and purchase a new one.

• 1. Remove the protective cap from the mouthpiece and check that the mouthpiece is clean and free of dust or other contaminants.
• 2. Perform a slow and deep exhalation.
• 3. Hold the canister in an upright position, with the stem pointing upwards, and then place the mouthpiece between your lips. Do not bite the mouthpiece.
• 4. Perform a slow and deep inhalation through your mouth. Immediately after starting inhalation, firmly pressthe top of the canister to release one inhalation of the medicine. Patients with a weak grip will find it easier to hold the inhaler with both hands: place both index fingers on the top of the canister and both thumbs on the bottom.
• 5. Hold your breath for as long as possible, then remove the inhaler from your mouth and perform a slow exhalation. Do not exhale into the inhaler.

To take another dose of the medicine, continue to hold the inhaler in an upright position for about half a minute, then repeat the steps described in points 2 to 5.
Important:The steps described in points 2 to 5 should not be performed too quickly.
After use, replace the protective cap and check the dose counter.
5/10
To reduce the risk of fungal infection of the mouth and throat, you should rinse your mouth or throat with water or brush your teeth after each inhalation.

If the dose counter shows 20, you should have a new inhaler ready.

You should stop using the inhaler if the counter shows 0, as the medicine left in the canister may not provide a full dose.

If a "mist" appears over the top opening of the mouthpiece or from the side of the mouth, it means that Formodual is not reaching the lungs as it should. You should take another dose, following the instructions, starting again from point 2.
If you feel that the effect of Formodual is too strong or too weak, you should consult a doctor or pharmacist.
If you have difficulty using the inhaler during inhalation, you can use a spacer (AeroChamber Plus). You should ask your doctor or pharmacist about this device.
It is essential to carefully read the leaflet that comes with the AeroChamber Plus spacer and follow the instructions for use and cleaning recommendations.

Cleaning the inhaler:

The inhaler should be cleaned once a week.

When cleaning, do not remove the canister from the plastic casing, and do not use water or other liquids to clean the inhaler.

Cleaning the inhaler:

• 1. Remove the protective cap from the mouthpiece by pulling it straight off the inhaler.
• 2. Wipe the mouthpiece and dose indicator on the inside and outside with a dry cloth or tissue.
• 3. Replace the protective cap.

Using a higher than recommended dose of Formodual

• using a higher than recommended dose of formoterol may cause the following symptoms: nausea, vomiting, rapid heartbeat, palpitations, arrhythmias, changes in electrocardiogram (ECG), headache, tremors, drowsiness, excessive acidic metabolic products in the blood, decreased potassium levels in the blood, increased glucose levels in the blood. The doctor may recommend a blood test to check potassium and glucose levels in the blood.
• using too high a dose of beclometasone dipropionate may cause temporary adrenal gland disorders, which resolve on their own within a few days. The doctor may recommend a blood test to check cortisol levels in the blood.

If you experience any of these symptoms, you should inform your doctor.

Missing a dose of Formodual

You should take the missed dose as soon as possible. If it is almost time for the next dose, do not take the missed dose, just take the next dose at the usual planned time. Do not take a double doseto make up for the missed dose.

Stopping treatment with Formodual

Even if you feel better, you should not stop taking Formodual or reduce the dose without consulting your doctor. It is essential to take the medicine regularly, even when symptoms of the disease have disappeared.
If you have any further doubts about using this medicine, you should consult a doctor or pharmacist.
6/10

4. Possible side effects

Like all medicines, Formodual can cause side effects, although not everybody gets them.
As with other inhaled medicines, there is a risk of worsening shortness of breath and wheezing immediately after taking Formodual, known as paradoxical bronchospasm.You should immediately STOP taking Formodualand use a fast-acting inhaled bronchodilator to relieve shortness of breath and wheezing. You should contact your doctor immediately.
You should immediately inform your doctorif you experience any allergic reactions, such as skin allergies, itching, rash, redness, swelling of the skin or mucous membranes, especially of the eyes, face, lips, and throat.
Other possible side effects are listed below, depending on their frequency.

• Frequent(occurring in less than 1 in 10 people):
• fungal infections (of the mouth and throat),
• headache,
• hoarseness,
• throat pain.

Uncommon(occurring in less than 1 in 100 people):

• palpitations, unusual rapid heartbeat, and arrhythmias,
• changes in electrocardiogram (ECG),
• increased blood pressure,
• flu-like symptoms,
• sinusitis,
• nasal congestion,
• ear infection,
• throat irritation,
• cough and cough with expectoration,
• asthma attack,
• vaginal fungal infections,
• nausea,
• taste disturbances,
• lip burning,
• dryness of the mouth and throat mucosa,
• difficulty swallowing,
• indigestion,
• upset stomach,
• diarrhea,
• muscle pain and muscle cramps,
• flushing,
• increased blood flow to some tissues,
• increased sweating,
• tremors,
• restlessness, especially motor restlessness,
• dizziness,
• hives.
• changes in some blood test results: decreased white blood cell count, increased platelet count,

7/10
decreased potassium levels in the blood,
increased glucose levels in the blood,
increased insulin, free fatty acids, and ketone bodies in the blood.
The following side effects have also been reported as "uncommon" in patients with chronic obstructive pulmonary disease:

• pneumonia: you should inform your doctor if you experience any of the following symptoms: increased production of sputum, change in sputum color, fever, increased cough, increased breathing problems,
• decreased cortisol levels in the blood, which is caused by the effect of corticosteroids on the adrenal glands,
• irregular heartbeat.

Rare(occurring in less than 1 in 1000 people):

• feeling of pressure in the chest,
• arrhythmias (caused by premature contraction of the heart chambers),
• decreased blood pressure,
• kidney inflammation,
• swelling of the skin and mucous membranes, lasting for several days.

Very rare(occurring in less than 1 in 10,000 people):

• shortness of breath,
• worsening of asthma,
• decreased platelet count,
• swelling of the hands and feet.

Using inhaled corticosteroids in high doses for a long time may

cause systemic effects in very rare cases.These include:

• adrenal gland disorders (adrenal gland suppression),
• decreased bone density (osteoporosis),
• delayed growth in children and adolescents,
• increased intraocular pressure (glaucoma),
• cataracts.

Frequency not known(cannot be estimated from the available data):

• sleep disturbances,
• depression or feeling depressed,
• nervousness,
• excessive excitement or irritability. These side effects are more likely to occur in children, but the frequency of these side effects is unknown.
• blurred vision.

Reporting side effects

If you experience any side effects, including any side effects not listed in this leaflet, you should tell your doctor, pharmacist, or nurse.
Side effects can be reported directly to the Department of Adverse Reaction Monitoring of Medicinal Products, Medical Devices, and Biocidal Products:
Al. Jerozolimskie 181C, 02-222 Warsaw,
phone: (22) 49 21 301, fax: (22) 49 21 309,
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
8/10
Reporting side effects will help to gather more information on the safety of this medicine.

5. How to store Formodual

The medicine should be stored out of sight and reach of children.
Information for the pharmacist:
Store in a refrigerator at a temperature between 2°C and 8°C. Store for a maximum of 18 months.
Information for the patient:
Do not use the medicine after 3 months from the date of dispensing from the pharmacy and do not use this medicine after the expiry date stated on the carton and label after "Exp". The expiry date refers to the last day of the month stated.
Do not store above 25°C.
If the inhaler has been exposed to very low temperatures, you should warm it in your hands for a few minutes before use. Never use other methods to heat the canister.
Important: The canister contains a pressurized liquid. Do not expose to temperatures above 50°C. Do not pierce the canister.
Medicines should not be disposed of via wastewater or household waste. You should ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.

6. Contents of the packaging and other information

What Formodual contains:

• The active substances of the medicine are beclometasone dipropionate and formoterol fumarate dihydrate. One dose of the medicine delivered by the inhaler contains 200 micrograms of beclometasone dipropionate and 6 micrograms of formoterol fumarate dihydrate. This corresponds to a dose delivered through the mouthpiece, containing 177.7 micrograms of beclometasone dipropionate and 5.1 micrograms of formoterol fumarate dihydrate.
• The other ingredients are norflurane (HFC 134a), anhydrous ethanol, hydrochloric acid. This medicine contains fluorinated greenhouse gases. Each inhaler contains 10.356 g of norflurane (HFC 134a), which corresponds to 0.015 tons of CO2 equivalent (GWP = 1430).

What Formodual looks like and what the pack contains

Formodual is available as a solution for inhalation, in an aluminum-coated canister with a dose counter, in a plastic casing with a mouthpiece, in a cardboard box. The casing is equipped with a plastic mouthpiece cover and has a dose counter (canister containing 120 doses) or dose indicator (canister containing 180 doses).
Each pack contains:

• one pressurized canister (which delivers 120 inhalations),
• two pressurized canisters (each delivering 120 inhalations),
• one pressurized canister (which delivers 180 inhalations). Not all pack sizes may be marketed.

9/10

Marketing authorization holder:

Chiesi Farmaceutici S.p.A, Via Palermo 26/A, 43122 Parma, Italy

Manufacturer:

Chiesi Farmaceutici S.p.A, Via San Leonardo 96, 43122 Parma, Italy
Chiesi Pharmaceuticals GmbH, Gonzagagasse 16/16, 1010 Vienna, Austria
Chiesi SAS, 2 rue des Docteurs Alberto et Paolo Chiesi, 41260 La Chaussee Saint Victor, France
To obtain detailed information, you should contact the local representative of the marketing authorization holder:
Chiesi Poland Sp. z o.o., Al. Jerozolimskie 134, 02-305 Warsaw
phone: (22) 620 14 21, fax: (22) 652 37 79, email: info-pl@chiesi.com

This medicinal product is authorized in the Member States of the European Economic Area under the following names:

Bulgaria, Cyprus, Estonia, Lithuania, Latvia, Romania: Foster
Belgium, Greece, Luxembourg: Inuvair
Denmark, Finland, Sweden: Innovair
France, Spain, Poland, United Kingdom: Formodual
Germany: Kantos Master
Ireland: Fostair
Italy: Inuver
Norway: Inuxair

Date of last revision of the leaflet: 12/2024

{Marketing authorization holder's logo}
10/10

4. Possible side effects

Like all medications, this medication can cause side effects, although they do not occur in everyone.
Similarly to other inhaled medications, there is a risk of worsening shortness of breath and wheezing immediately after taking Formodual, known as paradoxical bronchospasm.You should then immediately STOP taking Formodual
and use a fast-acting inhaled bronchodilator to relieve shortness of breath and wheezing. You should immediately contact your doctor.
You should immediately inform your doctorif you experience any allergic reactions,
such as: skin allergies, itching, skin rash, skin redness, skin or mucous membrane swelling, especially of the eyes, face, lips, and throat.
Other possible side effects are listed below, depending on the frequency of occurrence.

• fungal infections (of the mouth and throat),
• headache,
• hoarseness,
• sore throat.

Frequent(occurring in less than 1 in 10 people):

• heart palpitations, irregular heartbeats and arrhythmias,
• changes in the electrocardiogram (ECG),
• increased blood pressure,
• flu-like symptoms,
• sinusitis,
• nasal congestion,
• ear infection,
• throat irritation,
• cough and cough with expectoration,
• asthma attack,
• vaginal fungal infections,
• nausea,
• taste disorders,
• lip burning,
• dryness of the oral mucosa,
• difficulty swallowing,
• indigestion,
• stomach upset,
• diarrhea,
• muscle pain and cramps,
• facial redness,
• increased blood flow to some tissues,
• increased sweating,
• tremors,
• restlessness, especially motor,
• dizziness,
• hives.
• changes in the values of some blood parameters: decreased white blood cell count, increased platelet count, decreased potassium levels in the blood,

7/10
increased blood sugar levels,
increased insulin, free fatty acids, and ketone bodies in the blood.
The following side effects have also been reported as "uncommon" in patients with chronic obstructive pulmonary disease:

• pneumonia: you should inform your doctor if you experience any of the following symptoms: increased production of sputum, change in the color of sputum, fever, increased cough, increased breathing problems,
• decreased cortisol levels in the blood, which is caused by the effect of corticosteroids on the adrenal glands,
• irregular heartbeat.

Rare(occurring in less than 1 in 1000 people):

• feeling of pressure in the chest,
• heart rhythm disorders (caused by too early contraction of the heart chambers),
• decreased blood pressure,
• kidney inflammation,
• skin and mucous membrane swelling, lasting for several days.

Very rare(occurring in less than 1 in 10,000 people):

• shortness of breath,
• worsening of asthma,
• decreased platelet count,
• swelling of the hands and feet.

Using inhaled corticosteroids in high doses for a long time can

cause systemic side effects in very rare cases.These include:

• adrenal function disorders (adrenal suppression),
• decreased bone mineral density (osteoporosis),
• delayed growth in children and adolescents,
• increased intraocular pressure (glaucoma),
• cataract.

Frequency not known(cannot be determined from available data):

• sleep disorders,
• depression or feeling of sadness,
• nervousness,
• excessive excitement or irritability. These side effects are more likely to occur in children, but the frequency of these side effects is unknown.
• blurred vision.

Reporting side effects

If you experience any side effects, including any side effects not listed in the leaflet, you should tell your doctor, pharmacist, or nurse.
Side effects can be reported directly to the Department of Adverse Reaction Monitoring of Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products:
Jerozolimskie Avenue 181C, 02-222 Warsaw,
phone: (22) 49 21 301, fax: (22) 49 21 309,
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help to gather more information on the safety of the medication.
8/10

5. How to store Formodual

The medication should be stored out of sight and out of reach of children.
Information for the pharmacist:
Store in a refrigerator at a temperature between 2°C and 8°C. Store for a maximum of
18 months.
Information for the patient:
The medication should not be used after 3 months from the date of issue from the pharmacy and should not be used after the expiry date stated on the carton and label after the abbreviation "Exp". The expiry date indicates the last day of the given month.
Do not store above 25°C.
If the inhaler has been exposed to very low temperatures, before using the medication, you should warm it in your hands for a few minutes. Never use other methods to heat the container.
Important: The container contains a pressurized liquid. Do not expose to temperatures above 50°C. Do not pierce the container.
Medications should not be disposed of in wastewater or household waste. You should ask your pharmacist how to dispose of medications that are no longer used. This will help protect the environment.

6. Contents of the pack and other information

What Formodual contains:

• The active substances of the medication are: beclomethasone dipropionate and formoterol fumarate dihydrate. One metered dose from the inhaler contains 200 micrograms of beclomethasone dipropionate and 6 micrograms of formoterol fumarate dihydrate. This corresponds to a delivered dose through the mouthpiece, containing 177.7 micrograms of beclomethasone dipropionate and 5.1 micrograms of formoterol fumarate dihydrate.
• The other ingredients are: norflurane (HFC 134a), anhydrous ethanol, hydrochloric acid. This medication contains fluorinated greenhouse gases. Each inhaler contains 14.239 g of norflurane (HFC 134a), which corresponds to 0.020 tons of CO2 equivalent (global warming potential GWP =
• 1430).

What Formodual looks like and what the pack contains

Formodual is available as an inhalation solution, in an aluminum-coated container with a metering valve, placed in a plastic case, in a cardboard box. The case is equipped with a plastic mouthpiece cover and has a dose counter (container containing 120 doses) or dose indicator (container containing 180 doses).
Each pack contains:

• one pressurized container (which delivers 120 sprays),
• two pressurized containers (which deliver 120 sprays each),
• one pressurized container (which delivers 180 sprays). Not all pack sizes may be marketed.

Marketing authorization holder:

Chiesi Farmaceutici S.p.A, Via Palermo 26/A, 43122 Parma, Italy
9/10

Manufacturer:

Chiesi Farmaceutici S.p.A, Via San Leonardo 96, 43122 Parma, Italy
Chiesi Pharmaceuticals GmbH, Gonzagagasse 16/16, 1010 Vienna, Austria
Chiesi SAS, 2 rue des Docteurs Alberto et Paolo Chiesi, 41260 La Chaussee Saint Victor, France
To obtain detailed information, you should contact the local representative of the marketing authorization holder:
Chiesi Poland Sp. z o.o., Jerozolimskie Avenue 134, 02-305 Warsaw
phone: (22) 620 14 21, fax: (22) 652 37 79, e-mail: info-pl@chiesi.com

This medicinal product is authorized in the Member States of the European Economic Area under the following names:

Bulgaria, Cyprus, Estonia, Lithuania, Latvia, Romania: Foster
Belgium, Greece, Luxembourg: Inuvair
Denmark, Finland, Sweden: Innovair
France, Spain, Poland, United Kingdom: Formodual
Germany: Kantos Master
Ireland: Fostair
Italy: Inuver
Norway: Inuxair

Date of last revision of the leaflet: 12/2024

{Marketing authorization holder's logo}
10/10